@article{article, title = {{A randomized, double-blind, biomarker-selected, phase II clinical trial of maintenance poly ADP-ribose polymerase inhibition with rucaparib following chemotherapy for metastatic urothelial carcinoma}}, publisher = {{American Society of Clinical Oncology (ASCO)}}, url = {{}}, year = {{2022}}, month = {{8}}, author = {{Crabb SJ and Hussain S and Soulis E and Hinsley S and Dempsey L and Trevethan A and Song Y and Barber J and Frew J and Gale J and Faust G et al}}, doi = {{10.1200/jco.22.00405}}, volume = {{41}}, journal = {{Journal of Clinical Oncology}}, issue = {{1}}, pages = {{54-64}}, note = {{Accessed on 2025/04/12}}}